2. 您的位置
3. 首页
4. 会议论文
5. A 36-week multicenter,randomized,double-blind,placebo-controlled,parallel-group,Phase 3 clinical tri

A 36-week multicenter,randomized,double-blind,placebo-controlled,parallel-group,Phase 3 clinical tri

来源 :2019全国老年痴呆与认知障碍相关疾病学术大会 | 被引量 : 0次 | 上传用户：lnfssg

【摘 要】

：

　　BACKGROUND New therapies are urgently needed for Alzheimer disease(AD).Sodium oligomannate(GV-971)is a marine-derived oligosaccharide that has been shown to

【作 者】

：

XIAO Shi-fu 

【机 构】

：

971StudyGroup,DepartmentofGeriatricPsychiatry,ShanghaiMentalHealthCenter,ShanghaiJiaotongUniversityS

【出 处】

：

2019全国老年痴呆与认知障碍相关疾病学术大会

【发表日期】

：

2019年6期

【关键词】

：

clinical trial sodium oligomannate GV-971 Alzheimer disease 

下载到本地 , 更方便阅读

下载此文 赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

　　BACKGROUND New therapies are urgently needed for Alzheimer disease(AD).Sodium oligomannate(GV-971)is a marine-derived oligosaccharide that has been shown to decrease amyloid deposition,reduce neuroinflammation,reconstitute gut microbiota,and improve cognition in animal models of AD.

其他文献

吉西他滨治疗胰腺癌的药效预测性标志物的研究

　　胰腺癌(PDAC)是一种恶性程度极高并迅速致命的难治性恶性肿瘤,目前,吉西他滨仍为治疗PDAC 的一线化疗药物。本研究力图通过基因型表型的关联分析研究以确定与预测性吉西

会议

转录因子c-Maf泛素化酶的发现和多发性骨髓瘤的精准治疗

会议

内分泌相关的低血压

会议

Modulating balance of synaptic and extrasynaptic NMDA receptors as strategy for Alzheimer disease dr

　　The unbalance between synaptic(GluN2A,mediating the protective pathway)and extra-synaptic NMDA receptors(NMDARs)(GluN2B,mediating the excitotoxic pathway)ha

会议

Alzheimer diseaseGluN2AGluN2BifenprodilD-cycloserinedrug discovery

Targeting PRMT5 confers elimination of chronic myelogenous leukemia stem cells in combination with i

　　Leukemia stem cells(LSCs)insensitive to imatinib are believed to be responsible for resistance to BCR-ABL tyrosine kinase inhibitors and relapse of chronic

会议

MiR-194 functions as a tumor suppressor in laryngeal squamous cell carcinoma by targeting Wee1

　　The emerging roles of microRNAs(miRs)have been deeply investigated in cancer.MiR-194 is deregulated in various cancers,whereas little is known about it in h

会议

Inflammation and dysregulation of immune response in Alzheimer disease,the drug target for the futur

　　It has been demonstrated that inflammation and dysregulation of immune response are involved in the pathogenesis of Alzheimer disease(AD).

会议

inflammationimmune responsedrug targetneurodegenerative disorders

肿瘤药理研究中的蛋白SUMO化修饰

会议

Inflammation-PQC in Ageing and DiseaseFocus on Autophagy and UPS in Cancer

会议

Use of Chinese herbal medicine to treat ADadvantageous efficacy and stimulation of PKA signaling at

　　OBJECTIVE Currently,almost all chemical compounds or biological reagents to reverse or slow down the AD process have failed in clinical trials.

会议

Chinese herbal medicinePKA signalingneural plasticitypTauTau toxicity